Upgrades
Piper Sandler upgraded the previous rating for Aligos Therapeutics Inc (NASDAQ:ALGS) from Neutral to Overweight. Aligos Therapeutics earned $0.44 in the third quarter, compared to $0.78 in the year-ago quarter. The current stock performance of Aligos Therapeutics shows a 52-week-high of $11.82 and a 52-week-low of $0.84. Moreover, at the end of the last trading period, the closing price was at $0.99.
According to Raymond James, the prior rating for TC Energy Corp (NYSE:TRP) was changed from Market Perform to Outperform. For the third quarter, TC Energy had an EPS of $0.82, compared to year-ago quarter EPS of $0.79. The stock has a 52-week-high of $59.38 and a 52-week-low of $38.35. At the end of the last trading period, TC Energy closed at $38.53.
For Skechers USA Inc (NYSE:SKX), Argus Research upgraded the previous rating of Hold to Buy. Skechers USA earned $0.55 in the third quarter, compared to $0.66 in the year-ago quarter. At the moment, the stock has a 52-week-high of $49.89 and a 52-week-low of $31.28. Skechers USA closed at $43.22 at the end of the last trading period.
For LifeStance Health Group Inc (NASDAQ:LFST), Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, LifeStance Health Gr showed an EPS of $0.11, compared to $0.35 from the year-ago quarter. The stock has a 52-week-high of $11.25 and a 52-week-low of $4.22. At the end of the last trading period, LifeStance Health Gr closed at $4.40.
For Sight Sciences Inc (NASDAQ:SGHT), Stifel upgraded the previous rating of Hold to Buy. For the third quarter, Sight Sciences had an EPS of $0.46, compared to year-ago quarter EPS of $0.43. The current stock performance of Sight Sciences shows a 52-week-high of $18.25 and a 52-week-low of $5.35. Moreover, at the end of the last trading period, the closing price was at $11.82.
For Borr Drilling Ltd (NYSE:BORR), BTIG upgraded the previous rating of Neutral to Buy. Borr Drilling earned $0.30 in the third quarter, compared to $0.24 in the year-ago quarter. At the moment, the stock has a 52-week-high of $6.96 and a 52-week-low of $1.75. Borr Drilling closed at $4.79 at the end of the last trading period.
For Western Digital Corp (NASDAQ:WDC), Benchmark upgraded the previous rating of Sell to Hold. Western Digital earned $0.20 in the first quarter, compared to $2.49 in the year-ago quarter. At the moment, the stock has a 52-week-high of $69.36 and a 52-week-low of $29.73. Western Digital closed at $35.23 at the end of the last trading period.
According to Wells Fargo, the prior rating for Sunnova Energy International Inc (NYSE:NOVA) was changed from Equal-Weight to Overweight. For the third quarter, Sunnova Energy Intl had an EPS of $0.54, compared to year-ago quarter EPS of $0.25. At the moment, the stock has a 52-week-high of $31.47 and a 52-week-low of $12.47. Sunnova Energy Intl closed at $17.10 at the end of the last trading period.
Wells Fargo upgraded the previous rating for First Solar Inc (NASDAQ:FSLR) from Equal-Weight to Overweight. For the third quarter, First Solar had an EPS of $0.46, compared to year-ago quarter EPS of $0.42. At the moment, the stock has a 52-week-high of $173.68 and a 52-week-low of $59.60. First Solar closed at $145.46 at the end of the last trading period.
For SunPower Corp (NASDAQ:SPWR), Wells Fargo upgraded the previous rating of Underweight to Equal-Weight. SunPower earned $0.13 in the third quarter, compared to $0.06 in the year-ago quarter. At the moment, the stock has a 52-week-high of $28.42 and a 52-week-low of $12.78. SunPower closed at $16.74 at the end of the last trading period.
According to Wells Fargo, the prior rating for Stitch Fix Inc (NASDAQ:SFIX) was changed from Underweight to Equal-Weight. In the first quarter, Stitch Fix showed an EPS of $0.50, compared to $0.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of $20.17 and a 52-week-low of $2.63. Stitch Fix closed at $3.50 at the end of the last trading period.
According to JP Morgan, the prior rating for Voya Financial Inc (NYSE:VOYA) was changed from Neutral to Overweight. Voya Financial earned $2.30 in the third quarter, compared to $1.36 in the year-ago quarter. The current stock performance of Voya Financial shows a 52-week-high of $74.97 and a 52-week-low of $56.20. Moreover, at the end of the last trading period, the closing price was at $62.99.
Wells Fargo upgraded the previous rating for Lululemon Athletica Inc (NASDAQ:LULU) from Equal-Weight to Overweight. In the third quarter, Lululemon Athletica showed an EPS of $2.00, compared to $1.62 from the year-ago quarter. At the moment, the stock has a 52-week-high of $410.70 and a 52-week-low of $251.51. Lululemon Athletica closed at $325.93 at the end of the last trading period.
Wells Fargo upgraded the previous rating for PVH Corp (NYSE:PVH) from Equal-Weight to Overweight. In the third quarter, PVH showed an EPS of $2.60, compared to $2.67 from the year-ago quarter. The stock has a 52-week-high of $113.78 and a 52-week-low of $43.49. At the end of the last trading period, PVH closed at $76.84.
According to Cowen & Co., the prior rating for Molson Coors Beverage Co (NYSE:TAP) was changed from Market Perform to Outperform. For the third quarter, Molson Coors Beverage had an EPS of $1.32, compared to year-ago quarter EPS of $1.75. The current stock performance of Molson Coors Beverage shows a 52-week-high of $60.12 and a 52-week-low of $46.69. Moreover, at the end of the last trading period, the closing price was at $49.58.
According to Wells Fargo, the prior rating for Sunrun Inc (NASDAQ:RUN) was changed from Equal-Weight to Overweight. For the third quarter, Sunrun had an EPS of $0.96, compared to year-ago quarter EPS of $0.11. The stock has a 52-week-high of $39.13 and a 52-week-low of $16.80. At the end of the last trading period, Sunrun closed at $22.23.
For Aligos Therapeutics Inc (NASDAQ:ALGS), Jefferies upgraded the previous rating of Hold to Buy. For the third quarter, Aligos Therapeutics had an EPS of $0.44, compared to year-ago quarter EPS of $0.78. The stock has a 52-week-high of $11.82 and a 52-week-low of $0.84. At the end of the last trading period, Aligos Therapeutics closed at $0.99.
Jefferies upgraded the previous rating for Amarin Corp PLC (NASDAQ:AMRN) from Hold to Buy. For the third quarter, Amarin Corp had an EPS of $0.02, compared to year-ago quarter EPS of $0.03. The current stock performance of Amarin Corp shows a 52-week-high of $3.81 and a 52-week-low of $1.04. Moreover, at the end of the last trading period, the closing price was at $1.26.
According to Deutsche Bank, the prior rating for PNC Financial Services Group Inc (NYSE:PNC) was changed from Hold to Buy. For the third quarter, PNC Financial Services Gr had an EPS of $3.78, compared to year-ago quarter EPS of $3.75. The stock has a 52-week-high of $228.14 and a 52-week-low of $143.52. At the end of the last trading period, PNC Financial Services Gr closed at $159.37.
For Jacobs Solutions Inc (NYSE:J), Baird upgraded the previous rating of Neutral to Outperform. In the fourth quarter, Jacobs Solutions showed an EPS of $1.80, compared to $1.58 from the year-ago quarter. The current stock performance of Jacobs Solutions shows a 52-week-high of $150.32 and a 52-week-low of $106.78. Moreover, at the end of the last trading period, the closing price was at $123.61.
According to Baird, the prior rating for Allogene Therapeutics Inc (NASDAQ:ALLO) was changed from Neutral to Outperform. In the third quarter, Allogene Therapeutics showed an EPS of $0.58, compared to $0.57 from the year-ago quarter. At the moment, the stock has a 52-week-high of $17.49 and a 52-week-low of $5.41. Allogene Therapeutics closed at $5.81 at the end of the last trading period.
Piper Sandler upgraded the previous rating for Zynex Inc (NASDAQ:ZYXI) from Neutral to Overweight. In the third quarter, Zynex showed an EPS of $0.13, compared to $0.15 from the year-ago quarter. The current stock performance of Zynex shows a 52-week-high of $14.55 and a 52-week-low of $4.97. Moreover, at the end of the last trading period, the closing price was at $14.14.
For Regency Centers Corp (NASDAQ:REG), Baird upgraded the previous rating of Neutral to Outperform. Regency Centers earned $1.01 in the third quarter, compared to $1.12 in the year-ago quarter. The current stock performance of Regency Centers shows a 52-week-high of $78.45 and a 52-week-low of $51.97. Moreover, at the end of the last trading period, the closing price was at $62.29.
According to Baird, the prior rating for EastGroup Properties Inc (NYSE:EGP) was changed from Neutral to Outperform. For the third quarter, EastGroup Props had an EPS of $1.77, compared to year-ago quarter EPS of $1.55. The stock has a 52-week-high of $223.21 and a 52-week-low of $137.47. At the end of the last trading period, EastGroup Props closed at $145.87.
JonesTrading upgraded the previous rating for Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) from Sell to Hold. Deciphera Pharmaceuticals earned $0.55 in the third quarter, compared to $1.37 in the year-ago quarter. At the moment, the stock has a 52-week-high of $21.21 and a 52-week-low of $6.51. Deciphera Pharmaceuticals closed at $20.25 at the end of the last trading period.
According to Baird, the prior rating for Hudson Pacific Properties Inc (NYSE:HPP) was changed from Neutral to Outperform. For the third quarter, Hudson Pacific Properties had an EPS of $0.52, compared to year-ago quarter EPS of $0.50. At the moment, the stock has a 52-week-high of $28.66 and a 52-week-low of $9.16. Hudson Pacific Properties closed at $9.18 at the end of the last trading period.
See all analyst ratings upgrades.
Downgrades
For Embecta Corp (NASDAQ:EMBC), Morgan Stanley downgraded the previous rating of Equal-Weight to Underweight. In the fourth quarter, Embecta showed an EPS of $0.73, compared to $1.70 from the year-ago quarter. The stock has a 52-week-high of $36.64 and a 52-week-low of $23.62. At the end of the last trading period, Embecta closed at $25.14.
According to Craig-Hallum, the prior rating for Silvergate Capital Corp (NYSE:SI) was changed from Buy to Hold. Silvergate Capital earned $1.28 in the third quarter, compared to $0.88 in the year-ago quarter. At the moment, the stock has a 52-week-high of $162.65 and a 52-week-low of $11.14. Silvergate Capital closed at $12.57 at the end of the last trading period.
For Agiliti Inc (NYSE:AGTI), Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. Agiliti earned $0.19 in the third quarter, compared to $0.23 in the year-ago quarter. The stock has a 52-week-high of $23.25 and a 52-week-low of $14.15. At the end of the last trading period, Agiliti closed at $16.24.
According to Morgan Stanley, the prior rating for Heska Corp (NASDAQ:HSKA) was changed from Equal-Weight to Underweight. For the third quarter, Heska had an EPS of $0.41, compared to year-ago quarter EPS of $0.20. At the moment, the stock has a 52-week-high of $164.57 and a 52-week-low of $58.00. Heska closed at $62.54 at the end of the last trading period.
According to B of A Securities, the prior rating for Silvergate Capital Corp (NYSE:SI) was changed from Neutral to Underperform. For the third quarter, Silvergate Capital had an EPS of $1.28, compared to year-ago quarter EPS of $0.88. The stock has a 52-week-high of $162.65 and a 52-week-low of $11.14. At the end of the last trading period, Silvergate Capital closed at $12.57.
According to B of A Securities, the prior rating for Fate Therapeutics Inc (NASDAQ:FATE) was changed from Buy to Underperform. In the third quarter, Fate Therapeutics showed an EPS of $0.86, compared to $0.45 from the year-ago quarter. The current stock performance of Fate Therapeutics shows a 52-week-high of $56.64 and a 52-week-low of $9.56. Moreover, at the end of the last trading period, the closing price was at $11.00.
UBS downgraded the previous rating for Cano Health Inc (NYSE:CANO) from Buy to Neutral. For the third quarter, Cano Health had an EPS of $0.23, compared to year-ago quarter EPS of $0.14. The current stock performance of Cano Health shows a 52-week-high of $9.75 and a 52-week-low of $0.98. Moreover, at the end of the last trading period, the closing price was at $1.10.
For Fate Therapeutics Inc (NASDAQ:FATE), Stifel downgraded the previous rating of Buy to Hold. Fate Therapeutics earned $0.86 in the third quarter, compared to $0.45 in the year-ago quarter. The current stock performance of Fate Therapeutics shows a 52-week-high of $56.64 and a 52-week-low of $9.56. Moreover, at the end of the last trading period, the closing price was at $11.00.
For Ballard Power Systems Inc (NASDAQ:BLDP), Wells Fargo downgraded the previous rating of Equal-Weight to Underweight. In the third quarter, Ballard Power Systems showed an EPS of $0.14, compared to $0.10 from the year-ago quarter. At the moment, the stock has a 52-week-high of $12.71 and a 52-week-low of $4.43. Ballard Power Systems closed at $5.04 at the end of the last trading period.
For Ulta Beauty Inc (NASDAQ:ULTA), Wells Fargo downgraded the previous rating of Equal-Weight to Underweight. Ulta Beauty earned $5.34 in the third quarter, compared to $3.94 in the year-ago quarter. The current stock performance of Ulta Beauty shows a 52-week-high of $490.98 and a 52-week-low of $330.80. Moreover, at the end of the last trading period, the closing price was at $488.94.
According to Morgan Stanley, the prior rating for Baxter International Inc (NYSE:BAX) was changed from Overweight to Equal-Weight. In the third quarter, Baxter Intl showed an EPS of $0.82, compared to $1.02 from the year-ago quarter. The current stock performance of Baxter Intl shows a 52-week-high of $89.70 and a 52-week-low of $49.00. Moreover, at the end of the last trading period, the closing price was at $52.57.
Morgan Stanley downgraded the previous rating for Doximity Inc (NYSE:DOCS) from Equal-Weight to Underweight. For the second quarter, Doximity had an EPS of $0.17, compared to year-ago quarter EPS of $0.19. The stock has a 52-week-high of $64.95 and a 52-week-low of $22.91. At the end of the last trading period, Doximity closed at $32.01.
According to Scotiabank, the prior rating for Confluent Inc (NASDAQ:CFLT) was changed from Sector Outperform to Sector Perform. Confluent earned $0.13 in the third quarter, compared to $0.17 in the year-ago quarter. The stock has a 52-week-high of $81.11 and a 52-week-low of $16.48. At the end of the last trading period, Confluent closed at $17.93.
Barclays downgraded the previous rating for UWM Holdings Corp (NYSE:UWMC) from Equal-Weight to Underweight. For the third quarter, UWM Hldgs had an EPS of $0.16, compared to year-ago quarter EPS of $0.16. The stock has a 52-week-high of $6.10 and a 52-week-low of $2.84. At the end of the last trading period, UWM Hldgs closed at $3.59.
According to Barclays, the prior rating for Synchrony Financial (NYSE:SYF) was changed from Overweight to Equal-Weight. For the third quarter, Synchrony Finl had an EPS of $1.47, compared to year-ago quarter EPS of $2.00. At the moment, the stock has a 52-week-high of $50.20 and a 52-week-low of $27.21. Synchrony Finl closed at $31.98 at the end of the last trading period.
For Fate Therapeutics Inc (NASDAQ:FATE), Wedbush downgraded the previous rating of Outperform to Neutral. For the third quarter, Fate Therapeutics had an EPS of $0.86, compared to year-ago quarter EPS of $0.45. The current stock performance of Fate Therapeutics shows a 52-week-high of $56.64 and a 52-week-low of $9.56. Moreover, at the end of the last trading period, the closing price was at $11.00.
According to SVB Leerink, the prior rating for Graphite Bio Inc (NASDAQ:GRPH) was changed from Outperform to Market Perform. For the third quarter, Graphite Bio had an EPS of $0.45, compared to year-ago quarter EPS of $0.28. At the moment, the stock has a 52-week-high of $12.98 and a 52-week-low of $2.07. Graphite Bio closed at $3.06 at the end of the last trading period.
According to Wells Fargo, the prior rating for Bloom Energy Corp (NYSE:BE) was changed from Overweight to Equal-Weight. In the third quarter, Bloom Energy showed an EPS of $0.20, compared to $0.20 from the year-ago quarter. The current stock performance of Bloom Energy shows a 52-week-high of $31.47 and a 52-week-low of $11.47. Moreover, at the end of the last trading period, the closing price was at $19.16.
Wells Fargo downgraded the previous rating for The RealReal Inc (NASDAQ:REAL) from Overweight to Equal-Weight. For the third quarter, The RealReal had an EPS of $0.38, compared to year-ago quarter EPS of $0.47. The stock has a 52-week-high of $12.58 and a 52-week-low of $1.04. At the end of the last trading period, The RealReal closed at $1.20.
Raymond James downgraded the previous rating for Envestnet Inc (NYSE:ENV) from Strong Buy to Outperform. For the third quarter, Envestnet had an EPS of $0.45, compared to year-ago quarter EPS of $0.61. The current stock performance of Envestnet shows a 52-week-high of $84.58 and a 52-week-low of $41.72. Moreover, at the end of the last trading period, the closing price was at $62.66.
For Radian Group Inc (NYSE:RDN), Barclays downgraded the previous rating of Overweight to Equal-Weight. Radian Group earned $1.31 in the third quarter, compared to $0.67 in the year-ago quarter. The stock has a 52-week-high of $24.84 and a 52-week-low of $17.84. At the end of the last trading period, Radian Group closed at $18.93.
According to Wells Fargo, the prior rating for NovoCure Ltd (NASDAQ:NVCR) was changed from Overweight to Equal-Weight. In the third quarter, NovoCure showed an EPS of $0.25, compared to $0.13 from the year-ago quarter. At the moment, the stock has a 52-week-high of $120.03 and a 52-week-low of $56.39. NovoCure closed at $118.81 at the end of the last trading period.
According to Barclays, the prior rating for PennyMac Financial Services Inc (NYSE:PFSI) was changed from Overweight to Equal-Weight. For the third quarter, PennyMac Financial Servs had an EPS of $2.46, compared to year-ago quarter EPS of $3.80. At the moment, the stock has a 52-week-high of $70.44 and a 52-week-low of $38.53. PennyMac Financial Servs closed at $58.55 at the end of the last trading period.
Barclays downgraded the previous rating for Oportun Financial Corp (NASDAQ:OPRT) from Overweight to Equal-Weight. In the third quarter, Oportun Financial showed an EPS of $0.25, compared to $0.78 from the year-ago quarter. At the moment, the stock has a 52-week-high of $21.39 and a 52-week-low of $4.03. Oportun Financial closed at $5.55 at the end of the last trading period.
Barclays downgraded the previous rating for OneMain Holdings Inc (NYSE:OMF) from Overweight to Equal-Weight. In the third quarter, OneMain Holdings showed an EPS of $1.51, compared to $2.37 from the year-ago quarter. The stock has a 52-week-high of $55.50 and a 52-week-low of $28.77. At the end of the last trading period, OneMain Holdings closed at $34.42.
Barclays downgraded the previous rating for NMI Holdings Inc (NASDAQ:NMIH) from Overweight to Equal-Weight. In the third quarter, NMI Holdings showed an EPS of $0.90, compared to $0.71 from the year-ago quarter. The current stock performance of NMI Holdings shows a 52-week-high of $27.25 and a 52-week-low of $15.33. Moreover, at the end of the last trading period, the closing price was at $20.80.
For MGIC Investment Corp (NYSE:MTG), Barclays downgraded the previous rating of Overweight to Equal-Weight. MGIC Investment earned $0.86 in the third quarter, compared to $0.46 in the year-ago quarter. The current stock performance of MGIC Investment shows a 52-week-high of $16.84 and a 52-week-low of $11.38. Moreover, at the end of the last trading period, the closing price was at $12.90.
Barclays downgraded the previous rating for Essent Group Ltd (NYSE:ESNT) from Overweight to Equal-Weight. In the third quarter, Essent Gr showed an EPS of $1.66, compared to $1.84 from the year-ago quarter. The stock has a 52-week-high of $50.17 and a 52-week-low of $34.27. At the end of the last trading period, Essent Gr closed at $38.56.
According to Wells Fargo, the prior rating for Bath & Body Works Inc (NYSE:BBWI) was changed from Overweight to Equal-Weight. In the third quarter, Bath & Body Works showed an EPS of $0.40, compared to $0.92 from the year-ago quarter. The current stock performance of Bath & Body Works shows a 52-week-high of $71.49 and a 52-week-low of $25.75. Moreover, at the end of the last trading period, the closing price was at $46.79.
According to Barclays, the prior rating for Discover Financial Services (NYSE:DFS) was changed from Overweight to Equal-Weight. For the third quarter, Discover Financial had an EPS of $3.54, compared to year-ago quarter EPS of $3.54. At the moment, the stock has a 52-week-high of $130.81 and a 52-week-low of $87.64. Discover Financial closed at $99.55 at the end of the last trading period.
For VF Corp (NYSE:VFC), Wells Fargo downgraded the previous rating of Equal-Weight to Underweight. In the second quarter, VF showed an EPS of $0.73, compared to $1.11 from the year-ago quarter. The stock has a 52-week-high of $76.61 and a 52-week-low of $25.05. At the end of the last trading period, VF closed at $29.45.
For Lincoln National Corp (NYSE:LNC), JP Morgan downgraded the previous rating of Overweight to Neutral. For the third quarter, Lincoln National had an EPS of $1.39, compared to year-ago quarter EPS of $1.62. The stock has a 52-week-high of $76.40 and a 52-week-low of $28.61. At the end of the last trading period, Lincoln National closed at $31.16.
According to JP Morgan, the prior rating for Silvergate Capital Corp (NYSE:SI) was changed from Overweight to Neutral. For the third quarter, Silvergate Capital had an EPS of $1.28, compared to year-ago quarter EPS of $0.88. The stock has a 52-week-high of $162.65 and a 52-week-low of $11.14. At the end of the last trading period, Silvergate Capital closed at $12.57.
According to Jefferies, the prior rating for Landos Biopharma Inc (NASDAQ:LABP) was changed from Hold to Underperform. In the third quarter, Landos Biopharma showed an EPS of $0.20, compared to $0.32 from the year-ago quarter. The stock has a 52-week-high of $4.92 and a 52-week-low of $0.21. At the end of the last trading period, Landos Biopharma closed at $0.54.
Cowen & Co. downgraded the previous rating for Fate Therapeutics Inc (NASDAQ:FATE) from Outperform to Market Perform. In the third quarter, Fate Therapeutics showed an EPS of $0.86, compared to $0.45 from the year-ago quarter. The stock has a 52-week-high of $56.64 and a 52-week-low of $9.56. At the end of the last trading period, Fate Therapeutics closed at $11.00.
For Constellation Brands Inc (NYSE:STZ), Cowen & Co. downgraded the previous rating of Outperform to Market Perform. In the third quarter, Constellation Brands showed an EPS of $2.83, compared to $3.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $261.52 and a 52-week-low of $207.59. Constellation Brands closed at $208.68 at the end of the last trading period.
According to Jefferies, the prior rating for Nuvation Bio Inc (NYSE:NUVB) was changed from Buy to Hold. In the third quarter, Nuvation Bio showed an EPS of $0.12, compared to $0.11 from the year-ago quarter. The current stock performance of Nuvation Bio shows a 52-week-high of $8.05 and a 52-week-low of $1.59. Moreover, at the end of the last trading period, the closing price was at $2.03.
According to Raymond James, the prior rating for AnaptysBio Inc (NASDAQ:ANAB) was changed from Outperform to Market Perform. For the third quarter, AnaptysBio had an EPS of $1.18, compared to year-ago quarter EPS of $0.24. The current stock performance of AnaptysBio shows a 52-week-high of $35.70 and a 52-week-low of $18.20. Moreover, at the end of the last trading period, the closing price was at $30.21.
Needham downgraded the previous rating for NuVasive Inc (NASDAQ:NUVA) from Buy to Hold. For the third quarter, NuVasive had an EPS of $0.54, compared to year-ago quarter EPS of $0.32. At the moment, the stock has a 52-week-high of $60.47 and a 52-week-low of $35.17. NuVasive closed at $42.37 at the end of the last trading period.
For Truist Financial Corp (NYSE:TFC), Deutsche Bank downgraded the previous rating of Buy to Hold. In the third quarter, Truist Financial showed an EPS of $1.24, compared to $1.42 from the year-ago quarter. The current stock performance of Truist Financial shows a 52-week-high of $68.95 and a 52-week-low of $40.01. Moreover, at the end of the last trading period, the closing price was at $44.44.
For Bank of America Corp (NYSE:BAC), Deutsche Bank downgraded the previous rating of Buy to Hold. Bank of America earned $0.81 in the third quarter, compared to $0.85 in the year-ago quarter. At the moment, the stock has a 52-week-high of $50.11 and a 52-week-low of $29.31. Bank of America closed at $34.07 at the end of the last trading period.
For JPMorgan Chase & Co (NYSE:JPM), Deutsche Bank downgraded the previous rating of Buy to Hold. In the third quarter, JPMorgan Chase showed an EPS of $3.12, compared to $3.74 from the year-ago quarter. The current stock performance of JPMorgan Chase shows a 52-week-high of $169.81 and a 52-week-low of $101.28. Moreover, at the end of the last trading period, the closing price was at $135.35.
Baird downgraded the previous rating for Triumph Group Inc (NYSE:TGI) from Outperform to Neutral. For the second quarter, Triumph Group had an EPS of $0.07, compared to year-ago quarter EPS of $0.10. At the moment, the stock has a 52-week-high of $27.85 and a 52-week-low of $7.84. Triumph Group closed at $10.32 at the end of the last trading period.
For Nevro Corp (NYSE:NVRO), Piper Sandler downgraded the previous rating of Neutral to Underweight. For the third quarter, Nevro had an EPS of $0.59, compared to year-ago quarter EPS of $0.87. The stock has a 52-week-high of $93.69 and a 52-week-low of $34.70. At the end of the last trading period, Nevro closed at $40.00.
According to BMO Capital, the prior rating for Graphite Bio Inc (NASDAQ:GRPH) was changed from Outperform to Market Perform. For the third quarter, Graphite Bio had an EPS of $0.45, compared to year-ago quarter EPS of $0.28. The stock has a 52-week-high of $12.98 and a 52-week-low of $2.07. At the end of the last trading period, Graphite Bio closed at $3.06.
For Fate Therapeutics Inc (NASDAQ:FATE), Piper Sandler downgraded the previous rating of Overweight to Neutral. Fate Therapeutics earned $0.86 in the third quarter, compared to $0.45 in the year-ago quarter. At the moment, the stock has a 52-week-high of $56.64 and a 52-week-low of $9.56. Fate Therapeutics closed at $11.00 at the end of the last trading period.
For Fate Therapeutics Inc (NASDAQ:FATE), BMO Capital downgraded the previous rating of Outperform to Market Perform. In the third quarter, Fate Therapeutics showed an EPS of $0.86, compared to $0.45 from the year-ago quarter. The stock has a 52-week-high of $56.64 and a 52-week-low of $9.56. At the end of the last trading period, Fate Therapeutics closed at $11.00.
For Fate Therapeutics Inc (NASDAQ:FATE), Truist Securities downgraded the previous rating of Buy to Hold. Fate Therapeutics earned $0.86 in the third quarter, compared to $0.45 in the year-ago quarter. The stock has a 52-week-high of $56.64 and a 52-week-low of $9.56. At the end of the last trading period, Fate Therapeutics closed at $11.00.
According to Baird, the prior rating for Getty Realty Corp (NYSE:GTY) was changed from Outperform to Neutral. In the third quarter, Getty Realty showed an EPS of $0.54, compared to $0.50 from the year-ago quarter. The stock has a 52-week-high of $35.77 and a 52-week-low of $24.66. At the end of the last trading period, Getty Realty closed at $34.43.
For Kite Realty Group Trust (NYSE:KRG), Baird downgraded the previous rating of Outperform to Neutral. For the third quarter, Kite Realty Gr Trust had an EPS of $0.48, compared to year-ago quarter EPS of $0.33. The current stock performance of Kite Realty Gr Trust shows a 52-week-high of $23.35 and a 52-week-low of $16.42. Moreover, at the end of the last trading period, the closing price was at $21.02.
See all analyst ratings downgrades.
Initiations
Dawson James initiated coverage on Zomedica Corp (AMEX:ZOM) with a Buy rating. The price target for Zomedica is set to $6.00. For the third quarter, Zomedica had an EPS of $0.01, compared to year-ago quarter EPS of $0.01. The current stock performance of Zomedica shows a 52-week-high of $0.50 and a 52-week-low of $0.15. Moreover, at the end of the last trading period, the closing price was at $0.19.
Credit Suisse initiated coverage on NewAmsterdam Pharma Co NV (NASDAQ:NAMS) with an Outperform rating. The price target for NewAmsterdam Pharma is set to $21.00. The stock has a 52-week-high of $32.88 and a 52-week-low of $7.52. At the end of the last trading period, NewAmsterdam Pharma closed at $11.93.
Morgan Stanley initiated coverage on Desktop Metal Inc (NYSE:DM) with a Equal-Weight rating. The price target for Desktop Metal is set to $1.75. In the third quarter, Desktop Metal showed an EPS of $0.10, compared to $0.10 from the year-ago quarter. The current stock performance of Desktop Metal shows a 52-week-high of $5.28 and a 52-week-low of $1.13. Moreover, at the end of the last trading period, the closing price was at $1.39.
With a Equal-Weight rating, Morgan Stanley initiated coverage on Otis Worldwide Corp (NYSE:OTIS). The price target seems to have been set at $84.00 for Otis Worldwide. For the third quarter, Otis Worldwide had an EPS of $0.80, compared to year-ago quarter EPS of $0.77. At the moment, the stock has a 52-week-high of $87.68 and a 52-week-low of $62.49. Otis Worldwide closed at $80.13 at the end of the last trading period.
Barclays initiated coverage on Ziff Davis Inc (NASDAQ:ZD) with a Equal-Weight rating. The price target for Ziff Davis is set to $88.00. For the third quarter, Ziff Davis had an EPS of $1.58, compared to year-ago quarter EPS of $2.34. The current stock performance of Ziff Davis shows a 52-week-high of $112.93 and a 52-week-low of $66.85. Moreover, at the end of the last trading period, the closing price was at $79.22.
Exane BNP Paribas initiated coverage on Equifax Inc (NYSE:EFX) with an Underperform rating. The price target for Equifax is set to $150.00. In the third quarter, Equifax showed an EPS of $1.73, compared to $1.85 from the year-ago quarter. The stock has a 52-week-high of $288.98 and a 52-week-low of $145.98. At the end of the last trading period, Equifax closed at $198.10.
Exane BNP Paribas initiated coverage on TransUnion (NYSE:TRU) with a Neutral rating. The price target for TransUnion is set to $64.50. TransUnion earned $0.93 in the third quarter, compared to $1.01 in the year-ago quarter. The current stock performance of TransUnion shows a 52-week-high of $118.49 and a 52-week-low of $50.32. Moreover, at the end of the last trading period, the closing price was at $59.33.
With a Buy rating, B of A Securities initiated coverage on Boot Barn Holdings Inc (NYSE:BOOT). The price target seems to have been set at $85.00 for Boot Barn Holdings. Boot Barn Holdings earned $1.06 in the second quarter, compared to $1.22 in the year-ago quarter. The current stock performance of Boot Barn Holdings shows a 52-week-high of $126.60 and a 52-week-low of $50.20. Moreover, at the end of the last trading period, the closing price was at $63.00.
B of A Securities initiated coverage on Celsius Holdings Inc (NASDAQ:CELH) with a Neutral rating. The price target for Celsius Holdings is set to $104.00. In the third quarter, Celsius Holdings showed an EPS of $0.67, compared to $0.03 from the year-ago quarter. The current stock performance of Celsius Holdings shows a 52-week-high of $122.24 and a 52-week-low of $38.31. Moreover, at the end of the last trading period, the closing price was at $101.23.
With an Overweight rating, Cantor Fitzgerald initiated coverage on Silver Spike Investment Corp (NASDAQ:SSIC). The price target seems to have been set at $15.30 for Silver Spike Investment.
With a Buy rating, Citigroup initiated coverage on Waste Management Inc (NYSE:WM). The price target seems to have been set at $183.00 for Waste Management. For the third quarter, Waste Management had an EPS of $1.56, compared to year-ago quarter EPS of $1.26. The current stock performance of Waste Management shows a 52-week-high of $175.98 and a 52-week-low of $138.58. Moreover, at the end of the last trading period, the closing price was at $153.88.
Wells Fargo initiated coverage on Snowflake Inc (NYSE:SNOW) with an Overweight rating. The price target for Snowflake is set to $170.00. For the third quarter, Snowflake had an EPS of $0.11, compared to year-ago quarter EPS of $0.04. The stock has a 52-week-high of $329.49 and a 52-week-low of $110.27. At the end of the last trading period, Snowflake closed at $121.56.
See all analyst ratings initiations.
